GlassScriptPhysician profile
Andrew Thomas Trobridge
NPI 1912965849
$253,408.31
in general payments reported to CMS, 2019-2025
38 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $13K · 2021: $53K · 2022: $49K · 2023: $51K · 2024: $33K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $63K · Travel and Lodging: $20K · Food and Beverage: $9,380 · Education: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $62,897.50 |
| Travel and Lodging | $20,048.11 |
| Food and Beverage | $9,379.80 |
| Education | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $179,235.66 | 2019-2025 | Ivas, Autoplex, Avaflex |
| Omnia Medical, LLC | $26,000.00 | 2021 | |
| Choice Spine, LLC | $25,753.11 | 2023-2025 | Triton, Thunderbolt Minimally Invasive Pedicle Screw Systems, Stratofuse |
| Spinal Simplicity, LLC | $9,715.65 | 2022-2025 | Ha Minuteman G3-R |
| Mml US, INC. | $2,754.05 | 2021 | |
| Boston Scientific Corporation | $1,675.20 | 2019-2025 | Wavewriter Alpha Prime 16, Artisan |
| Nalu Medical, INC. | $1,445.07 | 2025 | Nalu Neurostimulation System |
| Surgentec | $1,272.22 | 2021 | |
| Spinal Elements, INC. | $1,041.99 | 2021 | |
| 4web, INC. | $908.57 | 2019-2020 | |
| Flowonix Medical Incorporated | $551.54 | 2019 | |
| Globus Medical, INC. | $486.84 | 2022-2025 | Excelsiusgps Robotic Navigation System, Sable, Omnia |
| Neuroone Medical Technologies Corporation | $426.91 | 2022 | |
| Nanohive Medical LLC | $357.43 | 2022-2023 | Hive Standalone Alif |
| Spineart USA INC | $302.26 | 2023 | Perla Tl |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $243.15 | 2025 | Prospera |
| Theragen, INC. | $186.25 | 2024 | Actastim-S |
| Nevro Corp. | $151.33 | 2022 | |
| Stimwave Technologies Incorporated | $122.00 | 2020 | |
| Si-Bone, INC. | $121.97 | 2023 | |
| Lifenet Health | $113.97 | 2024 | Allograft Vmis Delivery System |
| Abbott Laboratories | $100.00 | 2022 | |
| Medtronic, INC. | $81.01 | 2024 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $61.28 | 2024 | Vivigen Mis Delivery System |
| Pfizer INC. | $47.59 | 2019-2021 | |
| Tersera Therapeutics LLC | $31.44 | 2019 | |
| Hologic Sales and Service, LLC | $29.65 | 2024 | Omni Hysteroscope, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Medtronic USA, INC. | $26.33 | 2020 | |
| Scilex Pharmaceuticals INC. | $21.35 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.86 | 2025 | |
| Biodelivery Sciences International, INC. | $17.20 | 2021 | |
| Merz Pharmaceuticals, LLC | $16.95 | 2024 | Xeomin |
| Teva Pharmaceuticals USA, INC. | $16.87 | 2025 | Austedo Xr |
| Abbvie INC. | $16.58 | 2022 | |
| Horizon Therapeutics Plc | $16.11 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.43 | 2019 | |
| Vertos Medical, INC. | $12.77 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Trobridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.